BioMarin Pharmaceutical Inc. (BMRN)

USD 64.69

(-3.72%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 6.84 Billion 6.37 Billion 6 Billion 5.84 Billion 4.69 Billion 4.42 Billion
Total Current Assets 2.95 Billion 2.75 Billion 2.27 Billion 2.34 Billion 1.94 Billion 2.05 Billion
Cash And Short Term Investments 1.07 Billion 1.29 Billion 1.01 Billion 1.06 Billion 753.8 Million 1.08 Billion
Cash and Cash Equivalents 755.12 Million 724.53 Million 587.27 Million 649.15 Million 437.44 Million 493.98 Million
Short Term Investments 318.68 Million 567 Million 426.59 Million 416.22 Million 316.36 Million 590.32 Million
Net Receivables 633.7 Million 461.31 Million 373.39 Million 448.35 Million 377.4 Million 342.63 Million
Inventory 1.1 Billion 894.08 Million 776.66 Million 698.54 Million 680.27 Million 530.87 Million
Other Current Assets 141.39 Million 104.52 Million 110.44 Million 129.93 Million 130.65 Million 98.4 Million
Total Non-Current Assets 3.88 Billion 3.62 Billion 3.72 Billion 3.5 Billion 2.74 Billion 2.37 Billion
Net PPE 1.11 Billion 1.07 Billion 1.03 Billion 1.03 Billion 1.01 Billion 948.68 Million
Good Will And Intangible Assets 490.9 Million 534.76 Million 584.85 Million 613.47 Million 653.61 Million 688.84 Million
Good Will 196.19 Million 196.19 Million 196.19 Million 196.19 Million 197.03 Million 197.03 Million
Intangible Assets 294.7 Million 338.56 Million 388.65 Million 417.27 Million 456.58 Million 491.8 Million
Long-Term Investments 615.38 Million 333.83 Million 507.79 Million 285.47 Million 411.97 Million 235.86 Million
Tax Assets 1.54 Billion 1.5 Billion 1.44 Billion 1.43 Billion 549.42 Million 460.95 Million
Other Non Current Assets 121.21 Million 176.23 Million 151.76 Million 142.23 Million 122 Million 36.56 Million
Other Assets - - - - - -
Total Liabilities 1.89 Billion 1.77 Billion 1.73 Billion 1.74 Billion 1.56 Billion 1.45 Billion
Total Current Liabilities 1.17 Billion 588.88 Million 539.82 Million 492.54 Million 932.5 Million 523.24 Million
Account Payables 315.5 Million 231.23 Million 193 Million 191.42 Million 570.62 Million 437.29 Million
Tax Payables 2.65 Million 16.21 Million 3.14 Million 19.22 Million 8.39 Million 7.78 Million
Short Term Debt 502.65 Million 10.37 Million 10.46 Million 11.75 Million 361.88 Million -
Deferred Revenue 4.62 Million 711 Thousand 6.95 Million 152 Thousand 13.03 Million -
Other Current Liabilities 354.23 Million 346.56 Million 329.39 Million 289.21 Million -13.03 Million 85.95 Million
Total Non Current Liabilities 713.03 Million 1.18 Billion 1.19 Billion 1.24 Billion 635.15 Million 935.94 Million
Long-Term Debt 593.09 Million 1.08 Billion 1.07 Billion 1.07 Billion 486.23 Million 830.41 Million
Deferred Revenue Non Current - - - - - -62.07 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 119.93 Million 100.01 Million 113.68 Million 174.32 Million 148.91 Million 105.53 Million
Other Liabilities - - - - - -
Total Equity 4.95 Billion 4.6 Billion 4.27 Billion 4.1 Billion 3.12 Billion 2.96 Billion
Stock Holders Equity 4.95 Billion 4.6 Billion 4.27 Billion 4.1 Billion 3.12 Billion 2.96 Billion
Common Stock 189 Thousand 186 Thousand 184 Thousand 182 Thousand 180 Thousand 178 Thousand
Retained Earnings -621.55 Million -789.19 Million -925.68 Million -861.6 Million -1.72 Billion -1.69 Billion
Accumulated other comprehensive income -38.64 Million -3.86 Million 14.43 Million -16.13 Million 20.16 Million 5.27 Million
Common Stock Equity 4.95 Billion 4.6 Billion 4.27 Billion 4.1 Billion 3.12 Billion 2.96 Billion
Capital Lease Obligation 38.12 Million 10.37 Million 10.46 Million 11.75 Million 10.7 Million -
Total Investments 934.06 Million 900.84 Million 934.39 Million 701.7 Million 728.33 Million 826.19 Million
Total Debt 1.13 Billion 1.08 Billion 1.07 Billion 1.07 Billion 848.12 Million 830.41 Million
Net Debt 378.74 Million 358.48 Million 491.8 Million 425.98 Million 410.67 Million 336.43 Million

Balance Sheet Charts